News

ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript

1 Mins read

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q3 2024 Earnings Conference Call November 13, 2024 8:00 AM ET

Company Participants

Alex Straus – Investor Relations
Richard Lowenthal – Co-Founder, President and CEO
Eric Karas – Chief Commercial Office
Kathleen Scott – CFO
Justin Chakma – Chief Business Officer

Conference Call Participants

Josh Schimmer – Cantor Fitzgerald
Ryan Deschner – Raymond James
Roanna Ruiz – Leerink Partners
Lachlan Hanbury-Brown – William Blair

Operator

Good day, and welcome to the ARS Pharmaceuticals Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Instructions will be given at that time. As a reminder, this call may be recorded.

I would now like to turn the call over to Alex Straus of Investor Relations. Please go ahead.

Alex Straus

Good morning and thank you for joining. With me on the call today are Richard Lowenthal, Co-Founder, President and CEO of ARS; Eric Karas, our Chief Commercial Office; Kathy Scott, our CFO; and Justin Chakma, our Chief Business Officer.

Earlier today, we issued a press release detailing our third quarter 2024 results and recent business highlights, which can be found on our website at ars-pharma.com. For today’s call, Rich will provide an overview of our recent corporate developments, Eric will provide an update on our neffy commercialization efforts, Kathy will provide a brief overview of our financial results, and the full team will join us for Q&A.

During today’s call, we’ll be making forward-looking statements based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties and our actual results may differ materially. Please see the risk factors in our SEC filings for additional details.

Now, let me turn the call over to Rich.

Richard Lowenthal

Thank you, Alex, and

Read the full article here

Related posts
News

Lucid Group Stock: Not Right EV Stock To Bank On, Not Fit For Mass Market (NASDAQ:LCID)

1 Mins read
This article was written by Follow With combined experience of covering technology companies on Wall Street and working in Silicon Valley, and…
News

Morgan Stanley: Some Of The Preferred Shares Still Yield 7% (NYSE:MS)

1 Mins read
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon….
News

Winnebago Industries, Inc. (WGO) Q1 2025 Earnings Call Transcript

1 Mins read
Winnebago Industries, Inc. (NYSE:WGO) Q1 2025 Earnings Conference Call December 20, 2024 10:00 AM ET Company Participants Ray Posadas – Vice President,…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *